Supernus Pharmaceuticals Inc
F:S49
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Supernus Pharmaceuticals Inc
F:S49
|
US |
|
C
|
Compass Inc
F:91D
|
US |
|
C
|
Clearside Biomedical Inc
XMUN:CLM
|
US |
|
P
|
Pultegroup Inc
XMUN:PU7
|
US |
|
G
|
Grupo Simec SAB de CV
AMEX:SIM
|
MX |
|
E
|
Ellaktor SA
XMUN:HLL
|
GR |
|
A
|
Agios Pharmaceuticals Inc
F:8AP
|
US |
|
D
|
DSV A/S
XMUN:DS81
|
DK |
|
D
|
Dell Technologies Inc
F:12DA
|
US |
|
M
|
Maven Brands Inc
XMUN:TLA
|
CA |
|
M
|
Mondi PLC
F:KYCA
|
UK |
Intrinsic Value
The intrinsic value for 
Supernus Pharmaceuticals Inc (S49) under the Base Case is hidden
EUR.
Compared with the current market price of 41.2 EUR, the stock appears hidden
.
S49 looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if S49 is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Supernus Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Supernus Pharmaceuticals Inc
Earnings Waterfall
Supernus Pharmaceuticals Inc
The intrinsic value for Supernus Pharmaceuticals Inc (S49) under the Base Case is hidden EUR.
Compared with the current market price of 41.2 EUR, the stock appears hidden.
